1. Home
  2. LXEO vs KF Comparison

LXEO vs KF Comparison

Compare LXEO & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • KF
  • Stock Information
  • Founded
  • LXEO 2017
  • KF 1984
  • Country
  • LXEO United States
  • KF United States
  • Employees
  • LXEO N/A
  • KF N/A
  • Industry
  • LXEO
  • KF Investment Managers
  • Sector
  • LXEO
  • KF Finance
  • Exchange
  • LXEO Nasdaq
  • KF Nasdaq
  • Market Cap
  • LXEO 93.9M
  • KF 90.9M
  • IPO Year
  • LXEO 2023
  • KF N/A
  • Fundamental
  • Price
  • LXEO $2.78
  • KF $22.70
  • Analyst Decision
  • LXEO Strong Buy
  • KF
  • Analyst Count
  • LXEO 6
  • KF 0
  • Target Price
  • LXEO $18.50
  • KF N/A
  • AVG Volume (30 Days)
  • LXEO 984.8K
  • KF 18.4K
  • Earning Date
  • LXEO 05-12-2025
  • KF 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • KF N/A
  • EPS Growth
  • LXEO N/A
  • KF N/A
  • EPS
  • LXEO N/A
  • KF N/A
  • Revenue
  • LXEO N/A
  • KF N/A
  • Revenue This Year
  • LXEO N/A
  • KF N/A
  • Revenue Next Year
  • LXEO N/A
  • KF N/A
  • P/E Ratio
  • LXEO N/A
  • KF N/A
  • Revenue Growth
  • LXEO N/A
  • KF N/A
  • 52 Week Low
  • LXEO $1.45
  • KF $18.30
  • 52 Week High
  • LXEO $19.50
  • KF $25.56
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 45.92
  • KF 65.28
  • Support Level
  • LXEO $2.51
  • KF $21.20
  • Resistance Level
  • LXEO $2.91
  • KF $22.87
  • Average True Range (ATR)
  • LXEO 0.38
  • KF 0.34
  • MACD
  • LXEO -0.04
  • KF 0.08
  • Stochastic Oscillator
  • LXEO 33.62
  • KF 84.12

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.

Share on Social Networks: